ReLIA (UDI 06971354100200)
Manufactured by ReLIA Biotechnologies (Jiangsu), Inc.
Device Regulatory Overview
The ReLIA (Model/Catalog Number: RF16214-50T) is a medical device manufactured by ReLIA Biotechnologies (Jiangsu), Inc.. This product is indexed under FDA Product Code / Category Classification W0102069013 within international Unique Device Identification (UDI) compliance databases.
Technical Specifications
- Model Number
- RF16214-50T
- Product Code / EMDN
- W0102069013
- Device Name
- Capillary Blood Procalcitonin Test (Fluorescence Immunoassay)
- Database Sync Date
- 2026-08-09 17:13:02
Full Regulatory Attributes
🔒 Token Gated
{
"review_panel": "AN",
"gudid_di_status": "Published",
"sterilization_methods": ["EO", "Gamma"],
"rx_only": true
}
Unlock Compliance Data & Serialization Specs
Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.
Get API Token Access ($49/mo)Frequently Asked Questions
Who is the primary manufacturer of ReLIA?
The registered manufacturer of record for ReLIA is ReLIA Biotechnologies (Jiangsu), Inc..
What is the Primary UDI-DI identifier for ReLIA?
The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is 06971354100200.
What classification code is assigned to this device?
This device is registered under product classification code W0102069013.
Similar Classification Devices (W0102069013)
Programmatic Export
Export this master device record as standardized JSON or CSV for compliance audits.
JSON API Endpoint